Skip to main content
Premium Trial:

Request an Annual Quote

PrimeSyn Lab Registers with FDA to Sell DNA Probes as ASRs

NEW YORK, Oct. 24 (GenomeWeb News) PrimeSyn Lab has registered with the US Food and Drug Administration to sell its DNA-based products as analyte-specific reagents, the company said in a statement dated Oct. 12.

 

PrimeSyn said in the statement that it is registered as a medical device manufacturer for custom DNA probes and primers used as analyte specific reagent products for in vitro diagnostic manufacturers.

 

The company can provide the ASRs to manufacturers without applying for any other approvals from the FDA, PrimeSyn told GenomeWeb News.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.